帕金森病中的疼痛和疲劳:探索它们的相互关系和调解变量
Alfonso Hurtado-Martínez1,2,3, Yeray González-Zamorano2,4,5,6, Marcos Moreno-Verdú2,7
1Escuela Internacional de Doctorado, Universidad Francisco de Vitoria, Pozuelo de Alarcón, Spain.
NeuroRehabilitation
|June 20, 2025
概括
这项研究发现,在帕金森病 (PD) 患者中,疲劳严重程度与疼痛干扰和负担之间存在中度联系. 焦虑和抑郁症显著影响了这种关系,突出了PD非运动症状的复杂相互作用.
科学领域:
- 神经学 神经学
- 精神病学是一个精神病学.
- 疼痛医学 医学 疼痛医学
背景情况:
- 帕金森病 (PD) 经常出现非运动性症状 (NMS),包括疼痛 (高达85%) 和疲劳.
- 疼痛和疲劳在PD的同时发生是常见的,并影响患者的幸福感.
- 疼痛和疲劳之间的特定关系,以及它们在PD中的介导因素,仍然没有得到充分的研究.
研究的目的:
- 调查帕金森病患者疼痛和疲劳之间的关联.
- 探索介导变量,如焦虑,抑郁和运动症状在疼痛疲劳关系中的作用.
主要方法:
- 一项涉及53名帕金森病患者疼痛的横截面研究.
- 使用的验证尺度:西班牙国王帕金森疼痛尺度 (S-KPPS),简要疼痛清单 (BPI),疲劳严重程度尺度 (FSS) 和每日疲劳影响尺度 (DFIS).
- 进行了相关性和部分相关性分析,控制了莱沃多巴当量每日剂量 (LEDD),疾病持续时间,UPDRS-III,焦虑,抑郁和运动恐惧症.
主要成果:
- 疲劳严重程度 (FSS) 与疼痛干扰 (BPI) 和症状负担 (S-KPPS) 显示出中度正相关性.
- 在疲劳严重程度和疼痛强度 (BPI) 或每日疲劳影响 (DFIS) 与任何疼痛维度之间没有发现显著的相关性.
- 焦虑,抑郁和运动恐惧症影响了疼痛疲劳相关性的意义,而LEDD和疾病持续时间没有.
结论:
- 在PD患者中,疲劳严重程度和疼痛干扰/负担之间存在中等相关性.
- 焦虑和抑郁等非运动性症状是PD中疼痛和疲劳之间的关系的重要影响因素.
- 这项研究确定疼痛是PD中相互关联的NMS四元体的一部分,与焦虑,抑郁和疲劳一起.
相关概念视频
01:15Parkinson's Disease: Overview
722
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
722
01:24Parkinson's Disease: Treatment
391
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
391
01:26Peripheral Artery Disease IV: Nursing Management
48
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
48
01:21Fatigue
249
Fatigue occurs when materials rupture under repeated or fluctuating loads, even at stress levels far below their static breaking strength. It typically results in brittle failure, even for ductile materials. It is a critical consideration in designing machines and structural components subjected to repetitive or varying loads. The nature of these loadings can range from fluctuating loads like unbalanced pump impellers causing vibrations to repeatedly bending a thin steel rod wire back and forth...
249
01:27Peripheral Artery Disease III: Interprofessional Care
34
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
34
01:25Analgesia and Pain Management
822
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
822